Internal Medicine, Pulmonary Disease · Buffalo, NY
NPI
1669421970
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
85 High St
Buffalo, NY, 14203
Phone (716) 630-1100
Groups this clinician bills Medicare through
Medicare paid, 2024
$103K
1,964 services
Medicare patients, 2024
718
Average age 73
Drug cost, 2024
$3.0M
6,170 prescriptions
Company payments, 2025
$133K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nashat H Rabadi was code 99213 (office e&m - established), 503 times for 397 patients. In total Nashat H Rabadi billed 1,964 services in 22 codes, and Medicare paid $103K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 503 | 397 | $60.66 | $31K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 313 | 287 | $12.06 | $3,775 |
| 94060 Pulmonary Function Testing | Office | 232 | 232 | $24.63 | $5,713 |
| 94729 Pulmonary Function Testing | Office | 230 | 230 | $32.78 | $7,540 |
| 94726 Pulmonary Function Testing | Office | 208 | 208 | $34.45 | $7,165 |
| 99291 Critical Care E&M | Facility | 197 | 75 | $153.92 | $30K |
| 99212 Office E&M - Established | Office | 115 | 106 | $35.12 | $4,039 |
| 99214 Office E&M - Established | Office | 95 | 88 | $89.60 | $8,512 |
| 99233 Hospital E&M - Subsequent | Facility | 28 | 26 | $88.84 | $2,487 |
| 99203 Office E&M - New | Office | 12 | 12 | $59.90 | $719 |
By year: 2022 $114K for 1,682 services; 2023 $116K for 1,847 services; 2024 $103K for 1,964 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nashat H Rabadi prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,065 prescriptions and refills. In total Nashat H Rabadi wrote 6,170 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,065 | 1,415 | 483 | $49K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 936 | 1,607 | 300 | $982K |
| Prednisone Generic | 602 | 662 | 294 | $2,670 |
| Azithromycin Generic | 439 | 470 | 236 | $3,836 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 324 | 649 | 117 | $87K |
| Breo Ellipta Fluticasone/Vilanterol | 238 | 405 | 70 | $155K |
| Montelukast Sodium Generic | 200 | 419 | 62 | $2,365 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 190 | 266 | 58 | $122K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 183 | 260 | 52 | $155K |
| Fluticasone Propionate Generic | 165 | 268 | 72 | $2,341 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 153 | 276 | 49 | $123K |
| Qvar Redihaler Beclomethasone Dipropionate | 132 | 176 | 48 | $42K |
| Ventolin Hfa Albuterol Sulfate | 104 | 136 | 36 | $9,455 |
| Spiriva Respimat Tiotropium Bromide | 101 | 169 | 42 | $84K |
| Omeprazole Generic | 100 | 173 | 31 | $1,167 |
Brand drugs: 3,373 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nashat H Rabadi $133K ($133K in general payments such as food, travel and fees) from 15 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $110K.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 64 | $110K |
| Viatris Specialty LLC | 24 | $7,813 |
| Grifols USA, LLC | 18 | $5,791 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $5,682 |
| GlaxoSmithKline, LLC. GSK | 31 | $1,932 |
| AstraZeneca Pharmaceuticals LP AZN | 16 | $578 |
| Genzyme Corporation SNY | 14 | $469 |
| Merck Sharp & Dohme LLC MRK | 3 | $181 |
| Regeneron Pharmaceuticals, Inc. REGN | 1 | $126 |
| Electromed, Inc. ELMD | 5 | $63.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.